- Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
-
Kang JY, Choi MS, Kim SJ, Kil JS, Lee JH, Koh KC, Paik SW, Yoo BC
- KMID: 1117695
- Korean J Hepatol.
- 2010 Dec;16(4):383-388.
- doi: 10.3350/kjhep.2010.16.4.383
BACKGROUND/AIMS: Transarterial chemoembolization (TACE) improves the survival of patients with unresectable hepatocellular carcinoma (HCC) and has been recommended as a first-line therapy for nonsurgical patients with large or multifocal HCC.... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm
-
Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW
- KMID: 1384055
- Korean J Hepatol.
- 2009 Dec;15(4):474-485.
- doi: 10.3350/kjhep.2009.15.4.474
BACKGROUND/AIMS: Radiofrequency ablation (RFA) is an established curative therapeutic modality for unresectable hepatocellular carcinoma (HCC), and transarterial chemoembolization (TACE) has been used as a palliative treatment for inoperable HCC. It... -
- CITED
-
- Close
- SHARE
-
- Close
